Tasiamide B

Tasiamide B is a linear peptide and Cathepsin D inhibitor derived from the marine cyanobacterium Symploca sp., serving as a valuable template for aspartic protease inhibitor development. It has demonstrated anti-cancer activity in research, notably against skin cancer models through HSP90 interaction, supporting its use in both in vitro and in vivo oncological studies.